Area of research
Global and Planetary Change · Economics and Econometrics
Research interest
Research interests include Medicine, Psychiatry, Placebo, Schizophrenia (object-oriented programming), Double blind, and Nivolumab.
Efficacy and safety of brexpiprazole in adolescents with schizophrenia: a multicountry, randomised, double-blind, placebo-controlled, phase 3 trial with an active reference
Patient-reported efficacy of adjunctive brexpiprazole in major depressive disorder in a phase 4, open-label, interventional study
PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma